Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study.

Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Mostardt S, Neumann A, Brockmeyer NH, Gelbrich G, Erbel R, Neumann T; German Competence Network Heart Failure; German Competence Network for HIV/AIDS.

Eur J Prev Cardiol. 2012 Apr;19(2):267-74. doi: 10.1177/1741826711398431. Epub 2011 Feb 28.

PMID:
21450595
2.

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.

Glass TR, Ungsedhapand C, Wolbers M, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC; Swiss HIV Cohort Study.

HIV Med. 2006 Sep;7(6):404-10.

3.
4.
5.
6.

Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.

Clin Ther. 2007 Jul;29(7):1448-55.

PMID:
17825696
7.

Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).

Erdine S, Ro YM, Tse HF, Howes LG, Aguilar-Salinas CA, Chaves H, Guindy R, Chopra P, Moller RA, Schou IM; Gemini-AALA Investigators.

J Hum Hypertens. 2009 Mar;23(3):196-210. doi: 10.1038/jhh.2008.114. Epub 2008 Sep 18.

PMID:
18800143
8.

Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients.

Myerson M, Poltavskiy E, Armstrong EJ, Kim S, Sharp V, Bang H.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):370-7. doi: 10.1097/QAI.0000000000000168.

PMID:
24732872
9.

[Prevalence of cardiovascular risk factors in HIV-infected patients].

Jericó C, Knobel H, Sorli ML, Montero M, Guelar A, Pedro-Botet J.

Rev Clin Esp. 2006 Dec;206(11):556-9. Spanish.

PMID:
17178075
10.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

AIDS. 2003 May 23;17(8):1179-93.

PMID:
12819520
11.

Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women.

Nanchahal K, Ashton WD, Wood DA.

J Hypertens. 2000 Jul;18(7):833-41.

PMID:
10930179
12.

Relative importance of borderline and elevated levels of coronary heart disease risk factors.

Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D'Agostino RB.

Ann Intern Med. 2005 Mar 15;142(6):393-402. Erratum in: Ann Intern Med. 2005 Apr 19;142(8):681.

PMID:
15767617
13.
14.

Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.

McNicoll S, Latour Y, Rondeau C, Bouthillier D, Davignon J, Genest J Jr.

Can J Cardiol. 1995 Feb;11(2):109-16.

PMID:
7866933
15.

Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).

Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW; DPV Initiative of the German Working Group for Pediatric Diabetology.

Diabetes Care. 2006 Feb;29(2):218-25.

PMID:
16443863
16.

Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.

Di Martino M, Degli Esposti L, Filigheddu F, Veronesi C, Salerno G, Saragoni S, Glorioso N, Didoni G, Degli Esposti E.

J Hum Hypertens. 2007 Jan;21(1):53-9. Epub 2006 Oct 12.

PMID:
17036042
17.

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.

PMID:
17919548
18.

[Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].

Slapikas R, Luksiene D, Slapikiene B, Babarskiene MR, Grybauskiene R, Linoniene L.

Medicina (Kaunas). 2005;41(11):925-31. Lithuanian.

19.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195
20.

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.

PMID:
17420118

Supplemental Content

Support Center